Logo Image
Business
Practice ManagementMalpractice ConsultHealth Law & Policy
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Conference ListingConference Previews Conference Recaps
Publications
Urology Times JournalEditorial Advisory BoardUrologists in Cancer CareSupplements and Featured PublicationsClinical Forums Recaps
More
CME/CE
Resources
Begin Your Journey: Tackling BurnoutSponsored MediaLive EventsInteractive ToolsJob BoardPartnersSponsored ResourcesTreatment Landscape Evolutions

Subscribe

  • Business
  • Watch
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Benign Conditions
  • Benign Prostatic Hyperplasia
  • Bladder Cancer
  • Female Urology
  • Genitourinary Cancers
  • Genomic Testing
  • Hormone Therapy
  • Kidney Cancer
  • Kidney Stones
    • Challenging Anatomy
  • Men's Health
  • Next-Generation Imaging
  • OAB and Incontinence
    • Voiding Dysfunction
  • Pediatrics
  • Prostate Cancer
    • Controveries in Urologic Cancer
    • Drug Therapy
  • Sexual Dysfunction
  • UTUC
  • Urologic Surgery
    • Cosmetic Surgery
Spotlight -
Peer Exchange|
Peers and Perspectives|
Case-Based Peer Perspectives|
Urology Times Journal
Advertisement

Spencer Hart, MD

Advertisement

Articles by Spencer Hart, MD

kentoh - Shutterstock.com

The expanding role of immunotherapy in urologic cancers

BySpencer Hart, MD,Gopal Gupta, MD
April 11th 2019

This article explores the current and potential future use of immunotherapy in prostate, kidney, and bladder cancer.

Advertisement

Latest Updated Articles

  • kentoh - Shutterstock.com
    The expanding role of immunotherapy in urologic cancers

    April 11th 2019



Advertisement
Advertisement

Trending on Urology Times

1

AMA issues Category I CPT codes for implantable tibial neuromodulation in UUI

2

Aglatimagene besadenovec shows sustained immune remodeling in localized prostate cancer

3

The UroOnc Minute: Key Updates to the AUA NMIBC Guideline, With Peter E. Clark, MD

4

John Sfakianos, MD, on integrating ctDNA into bladder cancer trials

5

Enzalutamide plus salvage radiotherapy associated with improved PFS in high-risk BCR

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us